Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Applied Therapeutics (APLT) stocks

Learn how to easily invest in Applied Therapeutics stocks.

Applied Therapeutics is a biotechnology business based in the US. Applied Therapeutics stocks (APLT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $24.77 – a decrease of 12.75% over the previous week. Applied Therapeutics employs 26 staff and has a trailing 12-month revenue of around $10.7 million.

How to buy Applied Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – APLT. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners

Promoted

National Bank Direct Brokerage


  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge


  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers


  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Applied Therapeutics stock price (NASDAQ:APLT)

Use our graph to track the performance of APLT stocks over time.

Applied Therapeutics shares at a glance

Information last updated 2023-05-27.
Latest market close$1.30
52-week range$0.50 - $2.18
50-day moving average $1.19
200-day moving average $1.04
Wall St. target price$7.67
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.35

Buy Applied Therapeutics stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
★★★★★
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
★★★★★
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95–$6.95
$0 if conditions met, or $100
N/A
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
$0
N/A
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Questrade
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
$0
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
★★★★★
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.
loading

Is it a good time to buy Applied Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Applied Therapeutics price performance over time

Historical closes compared with the close of $1.3 from 2023-05-26

1 week (2023-05-19) -12.75%
1 month (2023-04-28) -23.53%
3 months (2023-02-28) 28.71%
6 months (2022-11-28) 44.12%
1 year (2022-05-27) -15.58%
2 years (2021-05-27) -93.35%
3 years (2020-05-28) 46.92
5 years (2018-05-24) N/A
[/expander_content] [/expander]

Applied Therapeutics financials

Revenue TTM $10.7 million
Gross profit TTM $0
Return on assets TTM -93.08%
Return on equity TTM -366.97%
Profit margin 0%
Book value $-0.09
Market capitalisation $75.2 million

TTM: trailing 12 months

Applied Therapeutics share dividends

We're not expecting Applied Therapeutics to pay a dividend over the next 12 months.

Applied Therapeutics share price volatility

Over the last 12 months, Applied Therapeutics's shares have ranged in value from as little as $0.5 up to $2.18. A popular way to gauge a stock's volatility is its "beta".

APLT.US volatility(beta: 1.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Therapeutics's is 1.8892. This would suggest that Applied Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Applied Therapeutics overview

Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site